IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. (Q42848152)
Jump to navigation
Jump to search
scientific article published on October 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas. |
scientific article published on October 2010 |
Statements
IDH1 or IDH2 mutations predict longer survival and response to temozolomide in low-grade gliomas (English)
C Houillier
X Wang
G Kaloshi
K Mokhtari
R Guillevin
J Laffaire
S Paris
B Boisselier
F Laigle-Donadey
K Hoang-Xuan
M Sanson
J-Y Delattre
1 October 2010